170
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells

, &
Pages 387-396 | Published online: 21 Jan 2019

References

  • QuerfurthHWLaferlaFMAlzheimer’s diseaseN Engl J Med Overseas Ed20103624329344
  • AhmedTVander Jeugd ABlumDCognition and hippocampal synaptic plasticity in mice with a homozygous tau deletionNeurobiol Aging201435112474247824913895
  • De FeliceFGWuDLambertMPAlzheimer’s disease-type neuronal tau hyperphosphorylation induced by Aβ oligomersNeurobiol Aging20082991334134717403556
  • SiesHBerndtCJonesDPOxidative stressEncyclopedia Stress200762104548
  • GagnéFOxidative stressBiochemical Ecotoxicology: Principles and MethodsAmsterdamElsevier2014103115
  • GaoHMZhouHHongJSNADPH oxidases: novel therapeutic targets for neurodegenerative diseasesTrends Pharmacol Sci201233629530322503440
  • LimónIDDíazAMendietaLAmyloid-beta (25–35) impairs memory and increases NO in the temporal cortex of ratsNeurosci Res200963212913719084561
  • WangXWangWLiLPerryGLeeHGZhuXOxidative stress and mitochondrial dysfunction in Alzheimer’s diseaseBiochim Biophys Acta18422014812401247
  • GräffJTsaiLHThe potential of HDAC inhibitors as cognitive enhancersAnnu Rev Pharmacol Toxicol201353131133023294310
  • KanninenKMalmTMJyrkkänenHKNuclear factor erythroid 2-related factor 2 protects against beta amyloidMol Cell Neurosci200839330231318706502
  • PlotnikoffNP2007Cytokines: stress and immunityBoca Raton. FLCRC Press405
  • ManjiHKMooreGJChenGClinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the patho-physiology and treatment of manic-depressive illnessBiol Psychiatry200048874075411063971
  • NobleWPlanelEZehrCInhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivoProc Natl Acad Sci U S A2005102196990699515867159
  • ChumboatongWThummayotSGovitrapongPTocharusCJittiwatJTocharusJNeuroprotection of agomelatine against cerebral ischemia/reperfusion injury through an antiapoptotic pathway in ratNeurochem Int201710211412228012846
  • DemirdaşANazıroğluMÜnalGÖAgomelatine reduces brain, kidney and liver oxidative stress but increases plasma cytokine production in the rats with chronic mild stress-induced depressionMetab Brain Dis20163161445145327438049
  • YucelAYucelNOzkanlarSEffect of agomelatine on adult hippocampus apoptosis and neurogenesis using the stress model of ratsActa Histochem2016118329930426970810
  • PompiliMSerafiniGInnamoratiMAgomelatine, a novel intriguing antidepressant option enhancing neuroplasticity: a critical reviewWorld J Biol Psychiatry201314641243123530731
  • RosenbergRNLambracht-WashingtonDYuGXiaWGenomics of Alzheimer disease: a reviewJAMA Neurol201673786727135718
  • KillinLOStarrJMShiueIJRussTCEnvironmental risk factors for dementia: a systematic reviewBMC Geriatr201616117527729011
  • VioletMDelattreLTardivelMA major role for tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditionsFront Cell Neurosci2014868424672431
  • GheyaraALPonnusamyRDjukicBTau reduction prevents disease in a mouse model of Dravet syndromeAnn Neurol201476344345625042160
  • HongXPPengCXWeiWEssential role of tau phosphorylation in adult hippocampal neurogenesisHippocampus201020121339134919816983
  • ChungSHAberrant phosphorylation in the pathogenesis of Alzheimer’s diseaseBMB Rep200942846747419712581
  • HangerDPAndertonBHNobleWTau phosphorylation: the therapeutic challenge for neurodegenerative diseaseTrends Mol Med200915311211919246243
  • HooverBRReedMNSuJTau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegenerationNeuron20106861067108121172610
  • DickeyCAKamalALundgrenKThe high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteinsJ Clin Invest2007117364865817304350
  • LiuZZhouTZieglerACDimitrionPZuoLOxidative stress in neurodegenerative diseases: from molecular mechanisms to clinical applicationsOxid Med Cell Longev201720174111
  • SherringtonRRogaevEILiangYCloning of a gene bearing missense mutations in early-onset familial Alzheimer’s diseaseNature199537565347547607596406
  • BondaDJWangXPerryGOxidative stress in Alzheimer disease: a possibility for preventionNeuropharmacology2010594–529029420394761
  • AseervathamGSSivasudhaTJeyadeviRArul AnanthDEnvironmental factors and unhealthy lifestyle influence oxidative stress in humans – an overviewEnviron Sci Pollut Res Int20132074356436923636598
  • AbramovAYBerezhnovAVFedotovaEIZinchenkoVPDolgachevaLPInteraction of misfolded proteins and mitochondria in neurodegenerative disordersBiochem Soc Trans201745410251033
  • GiraldoELloretAFuchsbergerTViñaJAβ and tau toxicities in Alzheimer’s are linked via oxidative stress-induced p38 activation: protective role of vitamin ERedox Biol2014287387725061569
  • LaudonMFrydman-MaromATherapeutic effects of melatonin receptor agonists on sleep and comorbid disordersInt J Mol Sci2014159159241595025207602
  • PlesničarBKEfficacy and tolerability of agomelatine in the treatment of depressionPatient Prefer Adherence2014860361224833894
  • YigitturkGAcaraACErbasOThe antioxidant role of agomelatine and gallic acid on oxidative stress in STZ induced type I diabetic rat testesBiomed Pharmacother20178724024628061407
  • BrunnerPSözer-TopcularNJockersRPineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer’s diseaseEur J Histochem200650431131617213040
  • SavaskanEAyoubMARavidRReduced hippocampal MT2 melatonin receptor expression in Alzheimer’s diseaseJ Pineal Res2005381101615617532
  • ChinchalongpornVShuklaMGovitrapongPMelatonin ameliorates Aβ42-induced alteration of βAPP-processing secretases via the melatonin receptor through the Pin1/GSK3β/NF-κB pathway in SH-SY5Y cellsJ Pineal Res2018644e1247029352484
  • PappollaMAMatsubaraEVidalRMelatonin treatment enhances Aβ lymphatic clearance in a transgenic mouse model of amyloidosisCurr Alzheimer Res201815763764229637859
  • ShiYFangYYWeiYPMelatonin in synaptic impairments of Alzheimer’s diseaseJ Alzheimers Dis201863311629578489
  • CaballeroBVega-NaredoISierraVFavorable effects of a prolonged treatment with melatonin on the level of oxidative damage and neurodegeneration in senescence-accelerated miceJ Pineal Res200845330231118410310
  • DajaniRFraserERoeSMCrystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibitionCell2001105672173211440715
  • RanaAKSinghDTargeting glycogen synthase kinase-3 for oxidative stress and neuroinflammation: opportunities, challenges and future directions for cerebral stroke managementNeuropharmacology201813912413630017999
  • GeXHShaoLZhuGJOxymatrine attenuates brain hypoxic-ischemic injury from apoptosis and oxidative stress: role of p-Akt/GSK3beta/ HO-1/Nrf-2 signaling pathwayMetab Brain Dis20183361869187530032345
  • TerwelDMuyllaertDDewachterIAmyloid activates GSK-3beta to aggravate neuronal tauopathy in bigenic miceAm J Pathol2008172378679818258852
  • LeroyKBoutajangoutAAutheletMWoodgettJRAndertonBHBrionJPThe active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer’s diseaseActa Neuropathol20021032919911810173
  • HooperCKillickRLovestoneSThe GSK3 hypothesis of Alzheimer’s diseaseJ Neurochem200810461433143918088381
  • MaqboolMMobashirMHodaNPivotal role of glycogen synthase kinase-3: a therapeutic target for Alzheimer’s diseaseEur J Med Chem2016107638126562543
  • MorrisGBerkMMaesMPuriBKCould Alzheimer’s disease originate in the periphery and if so how so?Mol Neurobiol Epub2018429
  • WorbyCADixonJEPTENAnnu Rev Biochem201483164166924905788
  • RobbinsHLHagueAThe PI3K/Akt pathway in tumors of endocrine tissuesFront Endocrinol20166377–387188
  • MaJGuoXZhangJPTEN gene induces cell invasion and migration via regulating Akt/GSK-3β/β-catenin signaling pathway in human gastric cancerDig Dis Sci201762123415342529030742
  • ShenHLiLYangSMicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/ GSK3β signaling pathwayGene20165931849027523474
  • HeEPanFLiGLiJFractionated ionizing radiation promotes epithelial-mesenchymal transition in human esophageal cancer cells through PTEN deficiency-mediated Akt activationPLoS One2015105e012614926000878
  • LiuXYZhangLJChenZLiuLBThe PTEN inhibitor bpV (pic) promotes neuroprotection against amyloid β-peptide (25–35)-induced oxidative stress and neurotoxicityNeurol Res201739875876528436304
  • Pinto-AlmazánRSegura-UribeJJSoriano-UrsúaMAFarfán-GarcíaEDGallardoJMGuerra-AraizaCEffect of tibolone pretreatment on kinases and phosphatases that regulate the expression and phosphorylation of tau in the hippocampus of rats exposed to ozoneNeural Regen Res201813344029623928
  • CuiWWangSWangZWangZSunCZhangYInhibition of PTEN attenuates endoplasmic reticulum stress and apoptosis via activation of PI3K/Akt pathway in Alzheimer’s diseaseNeurochem Res201742113052306028819903
  • LaferlaFMGreenKNAnimal models of Alzheimer diseaseCold Spring Harb Perspect Med2012211a006320a00632923002015
  • GötzJIttnerLMAnimal models of Alzheimer’s disease and frontotemporal dementiaNat Rev Neurosci20089753254418568014